Inventor profile of:

Roger Adami

City:

Carlsbad, California

Country:

United States

Published Applications:

18

Last publication date:

2025-08-07

Top Assignees for applications by Roger Adami

The entities that hold a legal rights for patent applications filed by inventor Adami Roger:

Recent patent applications by Adami Roger

Roger Adami from Carlsbad, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-08-07
US20250250226A1
Chemistry; metallurgy

IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF

#2 | 2024-01-04
US20240000710A1
Human necessities

Compositions and methods for nanoparticle lyophile forms

#3 | 2022-09-01
US20220275373A1
Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR TREATING MALIGNANT TUMORS ASSOCIATED WITH KRAS MUTATION

#4 | 2022-08-04
US20220242820A1
Chemistry; metallurgy

Ionizable compounds and compositions and uses thereof

#5 | 2022-07-28
US20220233445A1
Human necessities

FUSOGENIC COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES

#6 | 2022-03-24
US20220087531A1
Human necessities

RNA INTERFERENCE COMPOSITIONS AND METHODS FOR MALIGNANT TUMORS

#7 | 2022-02-17
US20220049251A1
Chemistry; metallurgy

dsRNA Directed to Coronavirus Proteins

#8 | 2019-12-05
US20190367926A1
Chemistry; metallurgy

Methods and compositions for treating malignant tumors associated with KRAS mutation

#9 | 2019-08-01
US20190231695A1
Human necessities

Compositions and methods for nanoparticle lyophile forms

#10 | 2019-05-09
US20190133948A1
Human necessities

Fusogenic compounds for delivery of biologically active molecules

#11 | 2019-05-02
US20190127318A1
Chemistry; metallurgy

Ionizable compounds and compositions and uses thereof

#12 | 2018-08-23
US20180235995A1
Human necessities

RNA INTERFERENCE THERAPEUTICS AGAINST EBOLA VIRUS

#13 | 2018-01-04
US20180002702A1
Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR TREATING MALIGNANT TUMORS ASSOCIATED WITH KRAS MUTATION

#14 | 2017-06-15
US20170165289A1
Human necessities

Methods and compositions for treating malignant tumors associated with kras mutation

#15 | 2017-01-26
US20170020819A1
Human necessities

Compositions and methods for nanoparticle lyophile forms

#16 | 2016-12-29
US20160376229A1
Chemistry; metallurgy

Ionizable compounds and compositions and uses thereof

#17 | 2016-06-30
US20160186183A1
Chemistry; metallurgy

Methods and compositions for treating malignant tumors associated with KRAS mutation

#18 | 2016-06-30
US20160186182A1
Chemistry; metallurgy

RNA interference compositions and methods for malignant tumors

InventorID:

1577517 ⎘